DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,809 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $23,594 | +5.7% | 94,481 | -2.1% | 0.21% | +1.4% |
Q4 2023 | $22,317 | -8.8% | 96,471 | -2.2% | 0.21% | -16.1% |
Q3 2023 | $24,467 | +8.1% | 98,618 | +4.6% | 0.25% | +13.2% |
Q2 2023 | $22,624 | -8.0% | 94,267 | -3.4% | 0.22% | -11.0% |
Q1 2023 | $24,596 | -5.0% | 97,591 | 0.0% | 0.25% | -9.6% |
Q4 2022 | $25,902 | -99.9% | 97,591 | 0.0% | 0.27% | -7.8% |
Q3 2022 | $25,206,000 | +8.1% | 97,591 | +22.7% | 0.30% | +30.0% |
Q1 2022 | $23,326,000 | -13.0% | 79,520 | -2.4% | 0.23% | -4.6% |
Q4 2021 | $26,806,000 | +6.1% | 81,472 | -1.8% | 0.24% | +1.3% |
Q3 2021 | $25,270,000 | +13.4% | 83,005 | 0.0% | 0.24% | +14.6% |
Q2 2021 | $22,275,000 | +19.2% | 83,005 | 0.0% | 0.20% | +11.4% |
Q1 2021 | $18,683,000 | -6.2% | 83,005 | -7.5% | 0.18% | -7.5% |
Q4 2020 | $19,927,000 | -1.0% | 89,705 | -4.0% | 0.20% | -12.7% |
Q3 2020 | $20,124,000 | +17.6% | 93,455 | -3.4% | 0.23% | +11.8% |
Q2 2020 | $17,114,000 | +20.0% | 96,780 | -6.1% | 0.20% | +2.0% |
Q1 2020 | $14,261,000 | -10.2% | 103,030 | -0.5% | 0.20% | +13.6% |
Q4 2019 | $15,887,000 | +6.3% | 103,508 | 0.0% | 0.18% | -2.2% |
Q3 2019 | $14,949,000 | +4.1% | 103,508 | +3.0% | 0.18% | +2.9% |
Q2 2019 | $14,364,000 | +5.9% | 100,508 | -2.2% | 0.18% | +4.2% |
Q1 2019 | $13,566,000 | +17.2% | 102,758 | -8.5% | 0.17% | +5.7% |
Q4 2018 | $11,574,000 | +0.4% | 112,244 | +5.8% | 0.16% | +15.2% |
Q3 2018 | $11,526,000 | -0.8% | 106,077 | -9.9% | 0.14% | +0.7% |
Q2 2018 | $11,623,000 | +0.8% | 117,783 | 0.0% | 0.14% | -1.4% |
Q1 2018 | $11,532,000 | +1.5% | 117,783 | -3.8% | 0.14% | +4.5% |
Q4 2017 | $11,362,000 | -2.7% | 122,417 | -10.0% | 0.13% | -5.0% |
Q3 2017 | $11,673,000 | +1.6% | 136,087 | 0.0% | 0.14% | -2.8% |
Q2 2017 | $11,484,000 | -2.8% | 136,087 | -1.4% | 0.14% | -3.4% |
Q1 2017 | $11,811,000 | +105.0% | 138,087 | +86.5% | 0.15% | +104.1% |
Q4 2016 | $5,762,000 | -5.1% | 74,026 | -4.4% | 0.07% | -5.2% |
Q3 2016 | $6,069,000 | -22.4% | 77,426 | 0.0% | 0.08% | -25.2% |
Q2 2016 | $7,820,000 | +2.5% | 77,426 | -3.7% | 0.10% | +4.0% |
Q1 2016 | $7,629,000 | +3.3% | 80,426 | +1.1% | 0.10% | +5.3% |
Q4 2015 | $7,386,000 | -3.3% | 79,526 | -11.3% | 0.09% | -6.0% |
Q3 2015 | $7,637,000 | +5.8% | 89,626 | +6.3% | 0.10% | +16.3% |
Q2 2015 | $7,215,000 | -5.2% | 84,300 | -5.9% | 0.09% | -2.3% |
Q1 2015 | $7,607,000 | -4.6% | 89,600 | -3.7% | 0.09% | -3.3% |
Q4 2014 | $7,971,000 | -79.1% | 93,000 | -81.5% | 0.09% | -79.8% |
Q3 2014 | $38,111,000 | -8.5% | 501,600 | -5.2% | 0.45% | -6.8% |
Q2 2014 | $41,640,000 | +50.5% | 528,900 | +43.4% | 0.48% | +48.5% |
Q1 2014 | $27,668,000 | -8.5% | 368,900 | -5.8% | 0.33% | -7.4% |
Q4 2013 | $30,239,000 | +2.3% | 391,700 | -8.1% | 0.35% | +30.9% |
Q3 2013 | $29,552,000 | +8.5% | 426,300 | -0.9% | 0.27% | +4.7% |
Q2 2013 | $27,225,000 | – | 430,100 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |